Industry seeks damage limitation as India works out price control
This article was originally published in Scrip
Executive Summary
Even as a crucial meeting of a mini-cabinet of Indian ministers is due to meet on 27 September to discuss reining in drug prices in the country, industry groups are continuing to hope that the mechanism the politicians adopt is one that inflicts minimal damage.